Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36026 - 36050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Doxorubicin	Approved Investigational	MIR483	619552	downregulated	Doxorubicin results in decreased expression of MIR483 mRNA	11p15.5	A22468
Doxorubicin	Approved Investigational	MIR486-1	619554	upregulated	Doxorubicin results in increased expression of MIR486-1 mRNA	8p11.21	A22468
Doxorubicin	Approved Investigational	MIR489	574442	upregulated	Doxorubicin results in increased expression of MIR489 mRNA	7q21.3	A22468
Doxorubicin	Approved Investigational	MIR542	664617	upregulated	Doxorubicin results in increased expression of MIR542 mRNA	Xq26.3	A22468
Doxorubicin	Approved Investigational	MIR551B	693136	upregulated	Doxorubicin results in increased expression of MIR551B mRNA	3q26.2	A22468
Doxorubicin	Approved Investigational	MIR574	693159	downregulated	Doxorubicin results in decreased expression of MIR574 mRNA	4p14	A22468
Doxorubicin	Approved Investigational	MIR584	693169	downregulated	Doxorubicin results in decreased expression of MIR584 mRNA	5q32	A22468
Doxorubicin	Approved Investigational	MIR592	693177	upregulated	Doxorubicin results in increased expression of MIR592 mRNA	7q31.33	A22468
Doxorubicin	Approved Investigational	MIR636	693221	downregulated	Doxorubicin results in decreased expression of MIR636 mRNA	17q25.1	A22468
Doxorubicin	Approved Investigational	MIR638	693223	upregulated	Doxorubicin results in increased expression of MIR638 mRNA	19p13.2	A22449
Doxorubicin	Approved Investigational	MIR675	100033819	downregulated	Doxorubicin results in decreased expression of MIR675 mRNA	11p15.5	A22468
Doxorubicin	Approved Investigational	MIR708	100126333	upregulated	Doxorubicin results in increased expression of MIR708 mRNA	11q14.1	A22468
Doxorubicin	Approved Investigational	MIR744	100126313	downregulated	Doxorubicin results in decreased expression of MIR744 mRNA	17p12	A22468
Doxorubicin	Approved Investigational	MIR760	100126348	downregulated	Doxorubicin results in decreased expression of MIR760 mRNA	1p22.1	A22468
Doxorubicin	Approved Investigational	MIR885	100126334	downregulated	Doxorubicin results in decreased expression of MIR885 mRNA	3p25.3	A22468
Doxorubicin	Approved Investigational	MIRLET7B	406884	downregulated	Doxorubicin results in decreased expression of MIRLET7B mRNA	22q13.31	A22468
Doxorubicin	Approved Investigational	MIRLET7C	406885	downregulated	Doxorubicin results in decreased expression of MIRLET7C mRNA	21q21.1	A22468
Doxorubicin	Approved Investigational	MKI67	4288	downregulated	Doxorubicin results in decreased expression of MKI67 mRNA	10q26.2	A22430
Doxorubicin	Approved Investigational	MLLT3	4300	downregulated	Doxorubicin results in decreased expression of MLLT3 mRNA	9p21.3	A22426
Doxorubicin	Approved Investigational	MMP2	4313	upregulated	[AKR1B10 protein results in decreased susceptibility to Doxorubicin] which results in increased expression of MMP2 mRNA	16q12.2	A22469
Doxorubicin	Approved Investigational	MRPS18A	55168	upregulated	Doxorubicin results in increased expression of MRPS18A mRNA	6p21.1	A22426
Doxorubicin	Approved Investigational	MSH6	2956	downregulated	Doxorubicin results in decreased expression of MSH6 mRNA	2p16.3	A22426
Doxorubicin	Approved Investigational	MT1G	4495	upregulated	Doxorubicin results in increased expression of MT1G mRNA	16q13	A22424
Doxorubicin	Approved Investigational	MT1L	4500	upregulated	Doxorubicin results in increased expression of MT1L mRNA	16q13	A22424
Doxorubicin	Approved Investigational	MT2A	4502	upregulated	Doxorubicin results in increased expression of MT2A mRNA	16q13	A22424

Displaying entries 36026 - 36050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability